MoviPrep Articles
Salix swings to loss in 1st-qtr 2008
19 May 2008
Norgine starts exporting Moviprep to the USA
5 February 2007
Norgine's Moviprep gets UK authorization
13 March 2006
Norgine grants US Moviprep rights to Salix
19 December 2005
Showing 1-6 of 6 articles
- 1
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
